Clozapine reduces infiltration into the CNS by targeting migration in experimental autoimmune encephalomyelitis.

Taken together, our study indicates that clozapine protects against EAE by two different mechanisms; first, by reducing the chemoattractant proteins in the CNS; and second, by direct targeting the migration potential of peripheral immune cells.